RAPIGLINIDE VOG 0.5

Repaglinide voglibose tablet is a prescription antidiabetic combination used in appropriate patients with type 2 diabetes mellitus when diet, exercise, and other diabetes medicines do not provide adequate blood-glucose control. This combination brings together two medicines that work at different points in glucose regulation: repaglinide, which stimulates meal-related insulin release, and voglibose, an alpha-glucosidase inhibitor that helps reduce the digestion and absorption of carbohydrates from the intestine.

The combination is particularly relevant for controlling post-meal blood-glucose elevations. Current Indian pharmaceutical listings show repaglinide + voglibose tablets in strengths such as 0.5 mg + 0.3 mg, while India's Central Drugs Standard Control Organisation (CDSCO) maintains official information on fixed-dose combinations and their regulatory status.

Because formulations and approvals can differ by manufacturer and strength, buyers should check the exact composition on the prescription and product packaging rather than assuming that all repaglinide voglibose tablets are identical.

What Is Repaglinide Voglibose Tablet Used For?

The primary use of repaglinide voglibose tablet is to help control blood sugar in adults with type 2 diabetes. It may be considered when blood glucose—particularly around meals—remains inadequately controlled despite appropriate lifestyle measures or other prescribed therapies.

Repaglinide stimulates insulin secretion from functioning pancreatic beta cells. Its action is closely linked to meals, which is why prescribing information instructs patients to take repaglinide before meals and to skip the scheduled dose when a meal is skipped.

Voglibose works differently. It slows the breakdown of complex carbohydrates into absorbable glucose in the intestine, helping reduce the rise in blood sugar after eating. Combining these mechanisms can provide complementary control of postprandial glucose.

Key Benefits of Repaglinide Voglibose Tablets

1. Supports Better Blood-Glucose Control

The combination can help reduce elevated blood glucose in appropriately selected patients with type 2 diabetes. Repaglinide promotes insulin release around meals, while voglibose helps moderate carbohydrate absorption.

2. Helps Address Post-Meal Blood Sugar Spikes

Postprandial glucose can contribute significantly to overall glycemic exposure. The complementary actions of repaglinide and voglibose make the combination particularly relevant when meal-related glucose elevations remain a treatment concern.

3. Two Complementary Mechanisms in One Tablet

Using two active ingredients in a fixed-dose combination can simplify treatment compared with taking separate tablets, provided the combination and strength are specifically prescribed.

CDSCO explains that fixed-dose combinations contain two or more active ingredients for particular indications and are subject to regulatory evaluation for marketing in India.

4. May Be Useful When Single-Medicine Therapy Is Insufficient

A healthcare professional may consider combination therapy when one medicine does not provide adequate glycemic control. The decision depends on HbA1c, glucose patterns, diet, kidney and liver function, other medicines, and individual treatment goals.

How Does Repaglinide Voglibose Work?

Repaglinide: Repaglinide is a short-acting insulin secretagogue. It stimulates pancreatic beta cells to release insulin, helping reduce blood glucose after meals. Its insulin-releasing effect depends on functioning beta cells.

Voglibose: Voglibose belongs to the alpha-glucosidase inhibitor class. It delays carbohydrate digestion and glucose absorption in the intestine, which can help reduce post-meal glucose increases.

Because the two ingredients have different mechanisms, the combination is designed to target blood glucose through complementary pathways.

Common Side Effects of Repaglinide Voglibose Tablet

As with any prescription medicine, side effects can occur. The most important risk associated with repaglinide is hypoglycemia, particularly when food intake is inadequate or when it is combined with other glucose-lowering medicines. Recognized symptoms can include sweating, shaking, hunger, dizziness, weakness, confusion and rapid heartbeat. Severe hypoglycemia can be dangerous.

Possible gastrointestinal effects associated with this type of combination may include:

• Abdominal discomfort

• Gas or bloating

• Diarrhea

• Nausea

• Changes in bowel movements

Repaglinide prescribing information also lists headache and other adverse reactions.

Because the exact voglibose strength and formulation vary, the product-specific patient information should always be checked for the complete adverse-effect profile.

Important Precautions Before Taking Repaglinide Voglibose

Repaglinide requires careful attention to meal timing. Current prescribing information states that repaglinide should generally be taken within 30 minutes before a meal and that the dose should be skipped if the meal is skipped.

Tell your doctor or pharmacist if you have kidney or liver problems, recurrent hypoglycemia, irregular eating patterns, or take other diabetes medicines.

Drug interactions are also important. For example, repaglinide is contraindicated with gemfibrozil, and specific dose restrictions or precautions apply with medicines such as clopidogrel and cyclosporine.

Repaglinide is not intended for treatment of type 1 diabetes or diabetic ketoacidosis.

Buying Repaglinide Voglibose Tablet Online

If your search intent is “buy repaglinide voglibose tablet online,” “repaglinide voglibose tablet price,” or “repaglinide voglibose tablet for diabetes,” do not choose a product based solely on price.

Before purchasing, verify:

1. Exact composition of repaglinide and voglibose.

2. Strength per tablet and prescribed dose.

3. Manufacturer and product registration details.

4. Batch number and expiry date.

5. Sealed and undamaged packaging.

6. Pharmacy or seller credentials.

7. Prescription requirements in your location.

8. Storage conditions.

9. Product leaflet and dosing instructions.

10. Whether the product matches the medicine prescribed by your doctor.

Current Indian online pharmacy listings demonstrate that multiple strengths and brands can be available. For example, a listing updated on August 24, 2026 identifies a repaglinide 0.5 mg + voglibose 0.3 mg tablet and marks it as prescription-only.

For regulatory verification, buyers can consult CDSCO's official database and fixed-dose-combination information.

Repaglinide Voglibose and Lifestyle Management

Medication works best as part of comprehensive diabetes management. A suitable eating plan, regular physical activity, appropriate weight management, glucose monitoring when recommended, and regular medical follow-up remain important.

Do not increase the dose simply because blood glucose is temporarily high, and do not take an extra repaglinide dose to compensate for a missed dose unless your healthcare professional specifically instructs you to do so.

Conclusion

Repaglinide voglibose tablet is a prescription combination designed to help manage type 2 diabetes, particularly by addressing glucose elevations associated with meals. Repaglinide stimulates meal-related insulin release, while voglibose delays carbohydrate digestion and absorption, providing complementary glucose-lowering effects.

The main benefit is improved glycemic control in appropriately selected patients, but hypoglycemia is an important safety consideration with repaglinide, especially when meals are skipped or other glucose-lowering medicines are being used. Gastrointestinal effects may also occur with voglibose-containing treatment.

For buyers, the safest approach is to confirm the exact strength, manufacturer, prescription status, authenticity, and dosage instructions before purchasing. Because diabetes treatment is individualized, repaglinide voglibose should be taken only according to a healthcare professional's instructions.

Frequently Asked Questions 

1. What is the repaglinide-voglibose tablet used for?

Repaglinide voglibose tablet is used to help control blood sugar in adults with type 2 diabetes, particularly when lifestyle measures or other diabetes treatments do not provide sufficient control. Its two ingredients work through complementary mechanisms.

2. What are the benefits of repaglinide and voglibose together?

Repaglinide stimulates insulin release around meals, while voglibose slows carbohydrate digestion and absorption. Together, they can help reduce overall and post-meal blood-glucose levels in appropriately treated patients.

3. What are the common side effects of repaglinide voglibose tablets?

Possible side effects include low blood sugar, nausea, diarrhea, abdominal discomfort, gas, bloating and headache. The exact side-effect profile depends on the formulation and individual patient.

4. Should repaglinide be taken before or after food?

Repaglinide is generally taken within 30 minutes before a meal. If a meal is skipped, the scheduled repaglinide dose should also be skipped according to current prescribing information.

5. Can repaglinide voglibose cause low blood sugar?

Yes. Repaglinide can cause hypoglycemia. The risk may increase with missed meals, changes in physical activity, or use with other glucose-lowering medicines.

6. Can I buy repaglinide voglibose tablets online?

Where legally permitted, purchase them from a legitimate pharmacy and follow prescription requirements. Check the exact repaglinide/voglibose strength, manufacturer, batch number, expiry date and packaging before accepting the medicine.

7. What happens if I skip a meal after taking repaglinide?

Because repaglinide stimulates meal-related insulin release, taking it without eating can increase the risk of hypoglycemia. Current prescribing information specifically instructs patients to skip the scheduled dose when a meal is skipped.

8. Is repaglinide voglibose suitable for everyone with diabetes?

No. The appropriate treatment depends on the type of diabetes, glucose control, kidney and liver function, other medicines, meal patterns and individual health risks. A qualified healthcare professional should determine whether this combination is suitable.